Stress urinary incontinence is a common health problem that affects a large proportion of women in Britain. It poses physical and psychological implications for the affected women and is a frequent indication for referral to tertiary urology centres. Midurethral tape surgery (MUTS) has established itself as the standard first-line surgical treatment as a result of its low morbidity, short hospital stay and high long-term success. Failure of the initial surgery can present as persistent or recurrent symptoms. This is a major challenge to the treating urologists as a result of the complicated nature of the condition and the lack of strong evidence supporting individual treatment modalities. In this article we discuss the factors associated with MUTS failure and the surgical options for its treatment.
HannestadYSRortveitGSandvikH. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol2000; 53: 1150–1167.
2.
MinassianVAStewartWFWoodGC. Urinary incontinence in women: Variation in prevalence estimates and risk factors. Obstet Gynecol2008; 111 (Pt 1): 324–331.
3.
KwonBEKimGYSonYJ. Quality of life of women with urinary incontinence: A systematic literature review. Int Neurourol J2010; 14: 133–138.
4.
HunskaarSLoseGSykesDVossS. The prevalence of urinary incontinence in women in four European countries. BJU Int2004; 93: 324–330.
UlmstenUHenrikssonLJohnsonP. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct1996; 7: 81-85, discussion 85–86.
7.
DelormeE. Transobturator urethral suspension: Mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol2001; 11: 1306–1313.
8.
de LevalJ. Novel surgical technique for the treatment of female stress urinary incontinence: Transobturator vaginal tape inside-out. Eur Urol2003; 44: 724–730.
9.
RichterHEAlboMEZyczynskiHM. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med2010; 362: 2066–2076.
10.
LiapisABakasPCreatsasG. Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: Efficacy at 5- and 7-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct2008; 19: 1509–1512.
11.
LeeHNLeeYSHanJY. Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. Int Urogynecol J2010; 21: 1479–1483.
12.
HellbergDHolmgrenCLannerL. The very obese woman and the very old woman: Tension-free vaginal tape for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct2007; 18: 423–429.
13.
PugsleyHBarbrookCMayneCJ. Morbidity of incontinence surgery in women over 70 years old: A retrospective cohort study. BJOG2005; 112: 786–790.
14.
BumpRCSugermanHJFantlJA. Obesity and lower urinary tract function in women: Effect of surgically induced weight loss. Am J Obstet Gynecol1992; 167: 392-397, discussion 397–399.
15.
SubakLLWingRWestDS. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med2009; 360: 481–490.
16.
DeffieuxXDonnadieuACPorcherR. Long-term results of tension-free vaginal tape for female urinary incontinence: Follow up over 6 years. Int J Urol2007; 14: 521–526.
17.
MullerMKoebeleADevalB. Determinants of success and recurrence after suburetral free tape procedure for female urinary incontinence. J Gynecol Obstet Biol Reprod (Paris)2007; 36: 19-29. Epub 17January2007.
18.
RafiiADaraïEHaabF. Body mass index and outcome of tension-free vaginal tape. Eur Urol2003; 43: 288–292.
19.
JacksonSLScholesDBoykoEJ. Urinary incontinence and diabetes in postmenopausal women. Diabetes Care2005; 28: 1730–1738.
20.
DaneshgariFMooreCFrinjariH. Patient related risk factors for recurrent stress urinary incontinence surgery in women treated at a tertiary care center. J Urol2006; (Pt 1): 1493–1499.
21.
DeLanceyJO. Anatomy and biomechanics of genital prolapse. Clin Obstet Gynecol1993; 36: 897–909.
22.
BarberMDKleemanSKarramMM. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. Am J Obstet Gynecol2008; 199: 666. e1–e7.
23.
HolmgrenCNilssonSLannerL. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol2005; 106: 38–43.
24.
DebodinancePDelportePEngrandJB. Tension-free vaginal tape (TVT) in the treatment of urinary stress incontinence: 3 years experience involving 256 operations. Eur J Obstet Gynecol Reprod Biol2002; 105: 49–58.
25.
RezapourMFalconerCUlmstenU. Tension-free vaginal tape (TVT) in stress incontinent women with intrinsic sphincter deficiency (ISD) — a long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct2001; (Suppl 2): S12–S14.
26.
DallenbachPLuyetCJungo NancozC. Incidence and risk factors for reoperation after surgically managed urinary incontinence: A nested case control study. In: 41st annual meeting of the International Continence Society, Glasgow, Scotland, 6 September 2011.
27.
KociszewskiJRautenbergOPerucchiniD. Tape functionality: Sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn2008; 27: 485–490.
28.
YangJMYangSHHuangWC. Correlation of morphological alterations and functional impairment of the tension-free vaginal tape obturator procedure. J Urol2009; 181: 211–218.
29.
KociszewskiJRautenbergOKolbenS. Tape functionality: Position, change in shape, and outcome after TVT procedure — mid-term results. Int Urogynecol J2010; 21: 795–800.
30.
PatelAKChappleCR. Urodynamics in the management of female stress incontinence — which test and when?Curr Opin Urol2008; 18: 359–364.
31.
LemackGEXuYBrubakerL. Clinical and demographic factors associated with valsalva leak point pressure among women undergoing Burch bladder neck suspension or autologous rectus fascial sling procedures. Neurourol Urodyn2007; 26: 392–396.
32.
KuhnAKuhnPDreherE. The correlation of urethral resistance pressure with maximum urethral closure pressure and stress incontinence. Eur J Obstet Gynecol Reprod Biol2008; 136: 116–120.
33.
DmochowskiRRMiklosJRNortonPA. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol2003; 170 (Pt 1): 1259–1263.
34.
MariappanPBallantyneZN’DowJM. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev2005: CD004742.
35.
ChappleCRWeinAJBrubakerL. Stress incontinence injection therapy: What is best for our patients?Eur Urol2005; 48: 552–565.
36.
PickardRReaperJWynessL. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev2003: CD003881.
37.
Isom-BatzGZimmernPE. Collagen injection for female urinary incontinence after urethral or periurethral surgery. J Urol2009; 181: 701–704.
38.
SabadellJPozaJLEsguevaA. Usefulness of retropubic tape for recurrent stress incontinence after transobturator tape failure. Int Urogynecol J2011; 22: 1543–1547.
39.
LeeKSDooCKHanHD. Outcomes following repeat mid urethral synthetic sling after failure of the initial sling procedure: Rediscovery of the tension-free vaginal tape procedure. J Urol2007; 178 (Pt 1): 1370–1374.
40.
EandiJATanakaSTHellenthalNJ. Self-reported urinary continence outcomes for repeat midurethral synthetic sling placement. Int Braz J Urol2008; 34: 336–342.
41.
MooreRDGambleKMiklosJR. Tension-free vaginal tape sling for recurrent stress incontinence after transobturator tape sling failure. Int Urogynecol J Pelvic Floor Dysfunct2007; 18: 309–313.
42.
LiapisABakasPCreatsasG. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol2009; 5: 1450–1455.
43.
StavKDwyerPLRosamiliaA. Repeat synthetic mid urethral sling procedure for women with recurrent stress urinary incontinence. J Urol2010; 183: 241–246.
44.
TsivianANeumanMYulishE. Redo midurethral synthetic sling for female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct2007; 18: 23–26.
45.
AmundsenCLFlynnBJWebsterGD. Urethral erosion after synthetic and nonsynthetic pubovaginal slings: Differences in management and continence outcome. J Urol2003; 170: 134–137.
46.
Amaye-ObuFADrutzHP. Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol1999; 181: 1296–1307.
47.
SchlomerBMurraySHaverkornR. Secondary auto-logous fascia slings fare more poorly than primary slings. Neurourol Urodyn2010; 276–277.
48.
Department of Health (UK). Hospital episodes statistics, www.hesonline.nhs.uk (2012, accessed, May 21012.)
49.
ThomasKVennSNMundyAR. Outcome of the artificial urinary sphincter in female patients. J Urol2002; 167: 1720–1722.
50.
VayleuxBRigaudJLuyckxF. Female urinary incontinence and artificial urinary sphincter: study of efficacy and risk factors for failure and complications. Eur Urol2011; 59: 1048–1053.
51.
FichtnerJ. Follow-up after urinary diversion. Urol Int1999; 63: 40–45.
52.
PatilAMoranPDuckettJ. How do urogynaecologists treat failed suburethral slings? Experience from the British Society of Urogynaecology database and literature review. J Obstet Gynaecol2011; 31: 514–517.
53.
HashimHTerryTR. Management of recurrent urinary stress incontinence and urinary retention following midurethral sling insertion in women: The expert opinion. Ann R Coll Surg Eng2012; 94: 517–522.
